Radnor Capital Management LLC Increases Position in Aflac Incorporated (NYSE:AFL)

Radnor Capital Management LLC raised its position in Aflac Incorporated (NYSE:AFL) by 5.1% during the third quarter, HoldingsChannel reports. The firm owned 70,167 shares of the financial services provider’s stock after buying an additional 3,375 shares during the quarter. Aflac accounts for 1.2% of Radnor Capital Management LLC’s holdings, making the stock its 13th biggest position. Radnor Capital Management LLC’s holdings in Aflac were worth $7,845,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of AFL. Norden Group LLC purchased a new stake in shares of Aflac in the 1st quarter valued at approximately $215,000. Choreo LLC increased its position in shares of Aflac by 6.1% in the 1st quarter. Choreo LLC now owns 2,611 shares of the financial services provider’s stock valued at $224,000 after purchasing an additional 150 shares during the last quarter. Central Pacific Bank Trust Division purchased a new stake in shares of Aflac in the 1st quarter valued at approximately $253,000. GSA Capital Partners LLP acquired a new position in shares of Aflac in the 1st quarter valued at $631,000. Finally, Catalina Capital Group LLC boosted its holdings in shares of Aflac by 58.4% in the 1st quarter. Catalina Capital Group LLC now owns 4,027 shares of the financial services provider’s stock valued at $346,000 after buying an additional 1,484 shares in the last quarter. 67.44% of the stock is owned by hedge funds and other institutional investors.

Aflac Stock Up 1.0 %

Shares of Aflac stock opened at $105.52 on Wednesday. The company has a market cap of $59.09 billion, a P/E ratio of 15.89, a PEG ratio of 2.07 and a beta of 0.96. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.10 and a current ratio of 0.08. Aflac Incorporated has a one year low of $75.07 and a one year high of $115.50. The firm has a fifty day moving average of $110.42 and a two-hundred day moving average of $98.25.

Aflac (NYSE:AFL) last announced its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $2.16 EPS for the quarter, topping analysts’ consensus estimates of $1.69 by $0.47. The company had revenue of $2.95 billion during the quarter, compared to the consensus estimate of $4.30 billion. Aflac had a net margin of 22.02% and a return on equity of 16.34%. Aflac’s quarterly revenue was down 40.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.84 EPS. On average, analysts forecast that Aflac Incorporated will post 7.05 earnings per share for the current year.

Aflac Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 2nd. Shareholders of record on Wednesday, November 20th will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Wednesday, November 20th. This represents a $2.00 dividend on an annualized basis and a yield of 1.90%. Aflac’s payout ratio is currently 30.12%.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the stock. Bank of America upped their target price on shares of Aflac from $115.00 to $124.00 and gave the company a “buy” rating in a report on Thursday, October 10th. Evercore ISI upped their target price on shares of Aflac from $84.00 to $90.00 and gave the company an “underperform” rating in a report on Thursday, September 26th. Barclays assumed coverage on shares of Aflac in a report on Wednesday, September 4th. They issued an “underweight” rating and a $96.00 target price for the company. Citigroup upped their target price on shares of Aflac from $84.00 to $93.00 and gave the company a “neutral” rating in a report on Tuesday, July 23rd. Finally, UBS Group upped their target price on shares of Aflac from $84.00 to $109.00 and gave the company a “neutral” rating in a report on Wednesday, August 14th. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Aflac presently has a consensus rating of “Hold” and a consensus price target of $97.93.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.